Viewing it as multiple copies of individuals is helpful to conceptualize what IPW is doing (i.e., constructing a pseudo-population), but maybe less helpful for understanding the variance. To see why, consider the following two cases: (1) the propensity score is known, and (2) the propensity score is unknown and must be estimated.
Case 1: Propensity score is known
When the propensity score is known, we can simply use its value. Here, think of a randomized trial. Because the trial has a known treatment assignment mechanism, we know the true propensity score. So, we can simply use the IPW estimator and plug in the known values for all the units. When estimating the variance, we do not need to account for the 'multiple' copies. The simplest case is a 1:1 trial, so the unstabilized IPW would be 2 for everyone. But we don't need to account for the 'two' copies of everyone.
Case 2: Propensity score is unknown
When the propensity score is unknown, as in an observational study, we might instead try to estimate it. As the propensity score is being estimated, it has its own associated uncertainty. So, our variance estimator needs to incorporate both the uncertainty in our parameter of interest and uncertainty in the propensity score model parameters (i.e., the nuisance parameters).
To emphasize the distinction between the cases, it is that case 2 involves estimation of additional parameters. Hence we need to account for those. Both IPW estimators reweight individuals (regardless of whether the IPW are stabilized or not), so the important distinction is what exactly is being estimated (and has an associated uncertainty).
A source of possible confusion
In the IPW literature, there is a trick for variance estimation. Essentially, you can use the sandwich variance estimator that ignores the uncertainty for the propensity score model (case 2). Let's call this the GEE trick. Weirdly this variance estimator is conservative for the average treatment effect (ATE), which is not what you would normally expect. But it does work. Due to its ease of implementation through software for GEE, it has become a popular approach. However, the overlap of ideas (correlation between observations due to copies, GEE being used to account for correlated observations) I think people tend to confuse the ideas.
What about the bootstrap?
While the bootstrap is more computationally demanding, it is not conservative. So, when statistical power is important the bootstrap might be preferred when in case 2 and sample sizes are limited. A computationally simpler approach is to use the sandwich variance estimator but with the propensity score model and IPW estimator stacked together (traditionally software does not use this approach). For details on this, see the further readings.
Summary
The important part to consider is what is being estimated. When the propensity score is known, the variance estimator does not need to incorporate the uncertainty of the propensity score (because there is none). When the propensity score is being estimated, we need to account for that uncertainty. This can be done by using the GEE trick, bootstrapping, or by stacking the estimating equations and using the sandwich variance estimator.
Further readings
Reifeis, Sarah A., and Michael G. Hudgens. "On variance of the treatment effect in the treated when estimated by inverse probability weighting." American Journal of Epidemiology 191.6 (2022): 1092-1097. LINK
Ross, R. K., Zivich, P. N., Stringer, J. S., & Cole, S. R. (2024). M-estimation for common epidemiological measures: introduction and applied examples. International Journal of Epidemiology, 53(2), dyae030. LINK